#RadOnc

Can we achieve similar outcomes for lung #SABR in non-academic institutions compared to the major academic centres? This was an important question posed by @drdavidpalma Suresh Senan & @FJLagerwaard. This

Freddy E Escorcia

freddyeescorcia

OK #medtwitter #scitwitter #doubledocs #radonc and #newpi tweeps: I have been charged with discussing "Recruitment and Retention of Physician Scientists" in #radonc at a panel for @ASTRO_org #ASTRO20. What are

Nataniel Lester-Coll, MD

On now! @abhiAsolanki discussing the management of locally recurrent prostate cancer after EBRT #ASTRO20 #pcsm #radonc Great discussion of patient selection for salvage therapies and potential outcomes. Bottom line, we

cancerphysicist

For the first question: No trials showing higher pCR w/ higher dose. Trials are actually remarkably consistent (no difference):INTERACT https://pubmed.ncbi.nlm.nih.gov/31005204/ RECTAL-BOOST https://pubmed.ncbi.nlm.nih.gov/32565319/&nb

ErinGillespieMD

.@pewresearch found that 96% of Americans have cell phones and 81% have smartphones (up from 35% in 2011). I suspect that #disparities in patient access to #telehealth will solve themselves

A few years before the RTOG 0236 reported a local tumor control rate of 91% with lung SBRT (2010), the Z4033 trial explored RFA as an alternative. The key findings

RefleXion Medical

Thx to our team, collaborators, and #radonc SVP of Clinical and Medical Affairs, @SeanShirvaniMD → Don't miss these abstracts on Tuesday! Ready for abstracts this upcoming Tuesday #ASTRO2020 → Don't

Gita Suneja MD MS

TODAY is the @ASTRO_org @theNCI Diversity Symposium on Implicit Bias featuring #radonc greatness @DrWinkfield @reshmajagsi @pnbarry @alediazmd @terri95517721 @DrMalikaSiker Dr. Charles Thomas, Dr. Curt Deville. Don't miss it! Special Se

Kevin Stephans MD

(1/5) The COVID era is aperfect time to adopt single fraction lung SBRT. This is supported by tworandomized trials suggesting comparable outcome for 30-34 Gy in 1 fraction formedically inoperable

Monica Wood, MD

What a year it has been @ACRRFS! As we begin the #ACR2020 Virtual Annual Meeting this weekend, I’d like to thank our executive + nominating committee members who have worked

Henning Willers, MD

Honored to present in the S14 Session: New approaches in clinical particle radiotherapy chaired by @simonpowell213 + Armin Luehr (although I guess the slide deck turned out to be more

My 1st *Tweetorial*! We investigated cost-effectiveness of adding SABR to standard tx for pts with oligometastatic dz. Manuscript out in #RedJournal!TL;DR – Adding SABR was robustly cost-effective under a wide

madamperezident

Hi #PreMedTwitter, me again! With virtual interviews this year, I’m sure you’re feeling nervous about not getting to meet as many current med students, so I’ve come here to help